Email this page
Print
Bookmark and share
Bigger
Smaller
Download PDF
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NPS RADAR August 2004NPS RADAR August 2004
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| NPS RADAR August 2004 Professional publication - NPS RADAR - Complete issue | NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
| Carvedilol (Dilatrend) titration pack for heart failure Professional publication - NPS RADAR - Review | Reviews PBS listing for a new titration pack size of carvedilol for heart failure. Includes discussion of titration packs and their use, and warnings about abrupt withdrawal of beta blockers. |
| Ethacrynic acid (Edecrin) tablets Professional publication - NPS RADAR - Review | Reviews use of ethacrynic acid tablets for hypertension in patients hypersensitive to other oral diuretics. |
| Ezetimibe (Ezetrol) for dyslipidaemia Professional publication - NPS RADAR - Review | Reviews use of ezetimibe for dyslipidaemia as an alternative to statins or in combination with other statins. |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2004-08-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
